Sax Wealth Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.07M Buy
17,001
+5,364
+46% +$357K 0.04% 222
2026
Q1
$772K Sell
11,637
-2,900
-20% -$202K 0.04% 227
2025
Q4
$965K Sell
14,537
-359
-2% -$23.2K 0.05% 207
2025
Q3
$1M Sell
14,896
-95
-0.6% -$7.52K 0.05% 185
2025
Q2
$1.31M Sell
14,991
-146
-1% -$11.4K 0.08% 144
2025
Q1
$1.03M Buy
15,137
+853
+6% +$69.6K 0.07% 137
2024
Q4
$1.11M Buy
14,284
+8,226
+136% +$609K 0.09% 112
2024
Q3
$406K Sell
6,058
-2,423
-29% -$199K 0.04% 180
2024
Q2
$962K Buy
+8,481
New +$1.07M 0.09% 91

Other funds holding DXCM

Sax Wealth Advisors's DXCM Position: Q2 2026 in Review

Sax Wealth Advisors increased its DexCom (DXCM) stake by 46% in Q2 2026, buying an estimated $357K and bringing the position to 17,001 shares worth $1.07M. The position accounts for 0.04% of the portfolio, ranked #222.

Sax Wealth Advisors first reported a position in DXCM in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.31M in Q2 2025. 161 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Sax Wealth Advisors held 17,001 shares of DexCom worth $1.07M as of Q2 2026.
  • Sax Wealth Advisors bought 5,364 DexCom shares in Q2 2026, an estimated $357K.
  • DexCom made up 0.04% of Sax Wealth Advisors's portfolio in Q2 2026, its #222 holding.
  • Sax Wealth Advisors first reported a position in DexCom in Q2 2024 and has held it in 9 quarters since.
  • Sax Wealth Advisors's DexCom position peaked at $1.31M in Q2 2025.
  • 161 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Sax Wealth Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.